Zolinza and neuropathy peripheral Patient Reports February 11, 2012

Zolinza Side Effects Report #5651148-5
Zolinza side effect was reported by a Pharmacist from UNITED STATES on Feb 28, 2008. Male patient, 15 years of age, was diagnosed with t-cell lymphoma and was treated with Zolinza. After drug was administered, patient experienced the following side effects: neuropathy peripheral, t-cell lymphoma recurrent. Zolinza dosage: unknown. During the same period patient was treated with ALEMTUZUMAB, BORTEZOMIB, MEPERIDINE HYDROCHLORIDE, BACTRIM, VORICONAZOLE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Zolinza Side Effects Report #5661463-7
Zolinza side effect was reported by a Pharmacist from UNITED STATES on Mar 10, 2008. Male patient, 15 years of age, was diagnosed with t-cell lymphoma and was treated with Zolinza. After drug was administered, patient experienced the following side effects: adverse event, neuropathy peripheral, t-cell lymphoma recurrent. Zolinza dosage: unknown. During the same period patient was treated with ALEMTUZUMAB, BORTEZOMIB, MEPERIDINE HYDROCHLORIDE, BACTRIM, VORICONAZOLE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Zolinza Side Effects Report #5747851-9
Zolinza side effect was reported by a Pharmacist from UNITED STATES on May 20, 2008. Male patient, 15 years of age, weighting 156.5 lb, was diagnosed with t-cell lymphoma and was treated with Zolinza. After drug was administered, patient experienced the following side effects: adverse event, mucormycosis, neuralgia, neuropathy peripheral, t-cell lymphoma recurrent. Zolinza dosage: unknown. During the same period patient was treated with ALEMTUZUMAB, BORTEZOMIB, MEPERIDINE HYDROCHLORIDE, BACTRIM, VORICONAZOLE, ACETAMINOPHEN, NEURONTIN. Patient was hospitalized and became disabled. Patient died on 05/03/2008.

Zolinza Side Effects Report #6135888-X
Zolinza side effect was reported by a Pharmacist from UNITED STATES on May 20, 2008. Male patient, 15 years of age, weighting 156.5 lb, was diagnosed with t-cell lymphoma and was treated with Zolinza. After drug was administered, patient experienced the following side effects: mucormycosis, neuralgia, neuropathy peripheral, somnolence, t-cell lymphoma recurrent. Zolinza dosage: unknown. During the same period patient was treated with ALEMTUZUMAB, BORTEZOMIB, MEPERIDINE HYDROCHLORIDE, BACTRIM, VORICONAZOLE, ACETAMINOPHEN, NEURONTIN. Patient was hospitalized and became disabled. Patient died on 05/03/2008.